24 HR Guanfacine 2 MG Extended Release Oral Tablet Intuniv

1 INDICATIONS AND USAGE INTUNIV ® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14) ]. INTUNIV ® is a central alpha 2A -adrenergic receptor agonist indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications ( 1 , 14 ).

shire us manufacturing inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] diarrhoea` `[3] off label use` `[4] nausea` `[5] drug ineffective` `[6] pneumonia` `[7] pyrexia` `[8] rash` `[9] headache` `[10] dyspnoea`

4 years ago

OVAL WHITE 503 2mg

4 years ago

503 2mg OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING INTUNIV ® is supplied in 1 mg, 2 mg, 3 mg, and 4 mg strength extended-release tablets in 100 count bottles. 1 mg 2 mg 3 mg 4 mg Color white/off-white white/off-white green green Shape round Caplet round Caplet Debossment (top/bottom) 503 / 1 mg 503 / 2 mg 503 / 3 mg 503 / 4 mg NDC number 54092-513-02 54092-515-02 54092-517-02 54092-519-02 Storage - Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). See USP Controlled Room Temperature.

More pills like OVAL 503 2mg

Related Pills

24 HR guanfacine 1 MG Extended Release Oral Tablet Intuniv

Shire US Manufacturing Inc.

Intuniv 24 HR Guanfacine 3 MG Extended Release Oral Tablet Intuniv

Shire US Manufacturing Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site